Table 1 Characteristics of the study patients (N = 112).

From: Serum fibroblast growth factor 21 levels after out of hospital cardiac arrest are associated with neurological outcome

 

Good outcome

N = 73

Poor outcome

N = 39

P-value

Missing data

Good/poor outcome

Age (years)

58 (51–66)

66 (58–75)

 < 0.01*

0/0

Sex (male)

84%

80%

0.61

0/0

BMI (kg/m2)

26 (24–29)

26 (23–29)

0.86

0/2

Smoker (yes)

33%

41%

0.50

6/7

Bystander initiated resuscitation (yes)

90%

69%

 < 0.01*

0/0

Time to first unit (min)

7.0 (6.0–9.0)

7.0 (5.0–10)

0.91

0/0

Time to ROSCa (min)

17 (15–22)

25 (22–32)

 < 0.001*

0/0

APACHE II (point)

27 (24–29)

31 (26–35)

 < 0.01*

0/0

PaO2 group (high)

47%

54%

0.55

0/0

48-h highest PaO2 (kPa)

27 (21–32)

29 (22–31)

0.64

0/0

Time from ICU admission to highest PaO2 (h)

2.9 (1.9–8.0)

3.7 (1.7–10)

0.60

0/0

NSE 48 h (ng/ml)

17 (13–25)

49 (25–130)

 < 0.001*

0/3

FGF 21 (ng/ml)

Admission

0.66 (0.29–1.5)

1.1 (0.50–2.3)

0.04*

1/0

 24 h

0.92 (0.40–1.8)

0.84 (0.53–1.7)

0.87

0/1

 48 h

1.2 (0.46–2.3)

1.4 (0.43–2.9)

0.46

0/3

 72 h

0.57 (0.19–1.8)

1.2 (0.40–2.8)

0.03*

1/5

  1. Continuous variables: median (IQR), Mann Whitney U test; categorical variables: percentage of the whole, Fisher’s Exact test. Good outcome, 6-month Cerebral Performance Categories (CPC) 1–2; Poor outcome, 6-month CPC 3–5.
  2. *Difference between groups is statistically significant at the P < 0.05 level.
  3. aROSC between 10–45 min was an inclusion criterion for the study.